See other companies on Welcome to the Jungle

Gleamer

Medical-grade AI for radiology

Gleamer logo
21-100 employees
  • Healthcare
  • B2B
  • Artificial Intelligence
  • Science
  • MedTech
Torcy, France

Company mission

To increase diagnostic accuracy and improve patient care and the efficiency of clinical practices for health professionals.

Top investors

Our take

Gleamer, a French medtech startup founded in 2017, has developed a suite of AI-powered solutions to help radiologists detect and diagnose bone trauma lesions in scans, among other conditions.

Its flagship product, BoneView, assists radiologists in identifying bone trauma lesions and other subtle abnormalities that may go unnoticed by the human eye. Additionally, Gleamer has developed ChestView for detecting pulmonary pathologies, BoneMeasurement for automating MSK measurements, and BoneAge for estimating bone age with precision.

Recognising the growing demand for medical imaging services, Gleamer has successfully raised new capital to further its advancements. With this funding, the company aims to expand its product portfolio to encompass CT scans and mammography, providing even more diagnostic capabilities. Additionally, Gleamer plans to bolster its teams in both Europe and the US, enabling broader access to its technologies and facilitating collaboration with medical professionals worldwide.

Kirsty headshot

Kirsty

Company Specialist at Welcome to the Jungle

Company values

  • Seeking Medical Excellence: We want to meet and surpass expectations of healthcare professionals and put extra effort on building powerful solutions both from performance and UX perspectives
  • Embracing Diversity: We cherish a multicultural and open environment where all members of the team can be their authentic self and speak up their ideas. We love challenging ourselves and question what we do to find the most creative solutions as a team
  • Humble & Curious: We value active listening to stay alert, inquire about new needs and welcome different views and opinions, from our customers, partners, coworkers, and our entire ecosystem

Funding (last 2 of 5 rounds)

Dec 2024

$4.8m

GRANT

Jun 2023

$28.4m

SERIES B

Total funding: $42.8m

This company has top investors

Leadership

Christian Allouche

(CEO & Co-Founder)

Graduated from ESCP Business School with a Master's degree in Management, Economics and Finance. Previously co-founded BrainVectis and served as the CEO at MeltingDoc.

Nor-eddine Regnard

(Chief Medical Officer & Co-Founder)

Previously worked as a Teacher at Paris Descartes University, Montpellier University and Pierre and Marie Curie University. They are now a Partner Radiologist at RISF South France Imaging Network.

Alexis Ducarouge

(CTO & Co-Founder)

Graduated from the École Normale Supérieure with a Master's degree in Cognitive Science and Artificial Intelligence.

Job (1)

All locations

Sales & Account Management